Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1516 AL 1530

The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects

Müller-Nedebock AC, Brennan RR, Venter M, Pienaar IS, van der Westhuizen FH, Elson JL, Ross OA, Bardien S.

Neurochem Int. 2019 Oct;129:104495. doi: 10.1016/j.neuint.2019.104495. Epub 2019 Jun 21.

Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research

Al-Lawati H, Binkhathlan Z, Lavasanifar A.

Eur J Pharm Biopharm. 2019 Sep;142:179-194. doi: 10.1016/j.ejpb.2019.06.025. Epub 2019 Jun 21.

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

Stacy M, Sajatovic M, Kane JM, Cutler AJ, Liang GS, O'Brien CF, Correll CU.

Mov Disord. 2019 Aug;34(8):1203-1209. doi: 10.1002/mds.27769. Epub 2019 Jun 24.

Anti-Inflammatory Activities of Marine Algae in Neurodegenerative Diseases

Barbalace MC, Malaguti M, Giusti L, Lucacchini A, Hrelia S, Angeloni C.

Int J Mol Sci. 2019 Jun 22;20(12):3061. doi: 10.3390/ijms20123061.

Hyposmia as a Predictive Marker of Parkinson's Disease: A Systematic Review and Meta-Analysis

Sui X, Zhou C, Li J, Chen L, Yang X, Li F.

Biomed Res Int. 2019 May 19;2019:3753786. doi: 10.1155/2019/3753786. eCollection 2019.

Neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review

Zhang J, Wu J, Liu F, Tong L, Chen Z, Chen J, He H, Xu R, Ma Y, Huang C.

Eur J Pharmacol. 2019 Sep 5;858:172500. doi: 10.1016/j.ejphar.2019.172500. Epub 2019 Jun 22.

Advances in Biosynthesis, Pharmacology, and Pharmacokinetics of Pinocembrin, a Promising Natural Small-Molecule Drug

Shen X, Liu Y, Luo X, Yang Z.

Molecules. 2019 Jun 24;24(12):2323. doi: 10.3390/molecules24122323.

Towards seeing the visual impairments in Parkinson's disease: protocol for a multicentre observational, cross-sectional study

Borm CDJM, Werkmann M, Visser F, Peball M, Putz D, Seppi K, Poewe W, Notting IC, Vlaar A, Theelen T, Hoyng C, Bloem BR, de Vries NM.

BMC Neurol. 2019 Jun 25;19(1):141. doi: 10.1186/s12883-019-1365-8.

The impact of levodopa therapy-induced complications on quality of life in Parkinson's disease patients in Singapore

Wu J, Lim EC, Nadkarni NV, Tan EK, Kumar PM.

Sci Rep. 2019 Jun 25;9(1):9248. doi: 10.1038/s41598-019-45110-5.

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM.

J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25.

Fuzzy Classification Methods Based Diagnosis of Parkinson's disease from Speech Test Cases

Dastjerd NK, Sert OC, Ozyer T, Alhajj R.

Curr Aging Sci. 2019;12(2):100-120. doi: 10.2174/1874609812666190625140311.

Treatment of psychiatric disturbances in hypokinetic movement disorders

Berardelli I, Belvisi D, Pasquini M, Fabbrini A, Petrini F, Fabbrini G.

Expert Rev Neurother. 2019 Oct;19(10):965-981. doi: 10.1080/14737175.2019.1636648. Epub 2019 Jul 2.

Addressing sexuality and intimacy in people living with Parkinson's during palliative care and at the end of life

Wright J.

Br J Nurs. 2019 Jun 27;28(12):772-779. doi: 10.12968/bjon.2019.28.12.772.

Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome

Ceresnak SR, Pass RH, Dubin AM, Yang L, Motonaga KS, Hedlin H, Avasarala K, Trela A, McElhinney DB, Janson C, Nappo L, Ling XB, Gates GJ.

PLoS One. 2019 Jun 26;14(6):e0217282. doi: 10.1371/journal.pone.0217282. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias